Loading data
NXTCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 44.92 m USD | 41.49 m USD | 47.93 m USD | 54.2 m USD | 50.19 m USD |
| Operating profit | -57.62 m USD | -59.75 m USD | -67.64 m USD | -75.91 m USD | -70.77 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -55.84 m USD | -55.65 m USD | -62.72 m USD | -74.73 m USD | -69.39 m USD |
| Basic earnings per share | -19.65 USD/share | -23.88 USD/share | -2.25 USD/share | -2.69 USD/share | -2.51 USD/share |
| Diluted earnings per share | -19.65 USD/share | -23.88 USD/share | -2.25 USD/share | -2.69 USD/share | -2.51 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.